<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To observe the clinical effect of Yuantong Capsule (YTC) in treating vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Eighty-three patients of VD were randomized on ratio of 2:1 into two groups, the 54 patients in the treated group were treated with YTC orally administered, 3 times a day, 1 capsule in each time </plain></SENT>
<SENT sid="2" pm="."><plain>The remaining 29 patients in the control group were treated with Hydergine orally, 3 times a day, 2 mg in each time </plain></SENT>
<SENT sid="3" pm="."><plain>The therapeutic course for both groups was 2 months </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The therapeutic effect in the treated group was significantly better than that in the control group, significant difference (P &lt; 0.05 or P &lt; 0.01) was shown in comparison of the two groups in terms of the mini-mental state examination (MMSE) and activity of daily living (ADL) test, symptoms scoring, total effective rate, and laboratory indexes findings </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: The therapeutic effect of YTC in treating VD was obvious </plain></SENT>
</text></document>